HCA Healthcare(IT:1HCA)
€452.80-4.80 (-1.05%)
IT:1HCA
HCA Healthcare stock forecast
€452.80
At close:-4.80 (-1.05%)
HCA Healthcare (1HCA) Stock Forecast & Price Target
2 Followers
1HCA Analyst Ratings
Moderate Buy
8Buy7Hold1Sell
Based on 16 analysts giving stock ratings to HCA Healthcare in the past 3 months
1HCA Stock 12 Month Forecast
Average Price Target
€416.75▼(-7.96% Downside)Based on 16 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is EUR 416.75 with a high forecast of EUR 510.35 and a low forecast of EUR 340.23. The average price target represents a -7.96% change from the last price of EUR 452.80.
Past 12 Months12 Month ForecastJan2026Oct2026
High€510.35
Average€416.75
Low€340.23
Highest Price TargetHighest€510.35Average Price Target€416.75Lowest Price TargetLowest€340.23
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ann Hynes | Mizuho Securities | €443.20→€510.35 | buy | 12.71%Upside | Reiterated | 11/11/26 | ||
| Kevin Fischbeck | Bank of America Securities | ― | hold | ― | Reiterated | 11/05/26 | ||
| Lance Wilkes | Bernstein | €381.42→€421.71 | hold | -6.87%Downside | Reiterated | 11/04/26 | ||
| Stephen Baxter | Wells Fargo | €341.13→€419.02 | hold | -7.46%Downside | Reiterated | 11/02/26 | ||
| Craig Hettenbach | Morgan Stanley | €340.23 | sell | -24.86%Downside | Assigned | 10/29/26 | ||
| Andrew Mok CFA | Barclays | €346.50→€359.04 | hold | -20.71%Downside | Reiterated | 10/29/26 | ||
| Ben Hendrix | RBC Capital | €444.09→€466.48 | buy | 3.02%Upside | Reiterated | 10/29/26 | ||
| Matthew Gillmor CFA | KeyBanc | €438.72 | buy | -3.11%Downside | Reiterated | 10/28/26 | ||
| Sean Dodge | BMO Capital | €443.20 | buy | -2.12%Downside | Reiterated | 10/28/26 | ||
| Michael Ha | Robert W. Baird | €351.87→€366.20 | hold | -19.13%Downside | Reiterated | 10/28/26 | ||
 Unknown AnalystNot Ranked | Oppenheimer | €434.24 | buy | -4.10%Downside | Reiterated | 10/28/26 | ||
| Ryan Langston | TD Cowen | €411.86→€435.14 | buy | -3.90%Downside | Reiterated | 10/28/26 | ||
| Andrew Cooper | Raymond James | ― | hold | ― | Reiterated | 09/28/26 | ||
| Brian Tanquilut | Jefferies | €402.91 | buy | -11.02%Downside | Reiterated | 09/17/26 | ||
| Whit Mayo | Leerink Partners | ― | buy | ― | Reiterated | 09/17/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ann HynesMizuho Securities | BuyReiterated€443.20→€510.35 | 11/11/26 | 12.71%Upside | ||
| Kevin FischbeckBank of America Securities | HoldReiterated | 11/05/26 | ― | ||
| Lance WilkesBernstein | HoldReiterated€381.42→€421.71 | 11/04/26 | -6.87%Downside | ||
| Stephen BaxterWells Fargo | HoldReiterated€341.13→€419.02 | 11/02/26 | -7.46%Downside | ||
| Craig HettenbachMorgan Stanley | SellAssigned€340.23 | 10/29/26 | -24.86%Downside | ||
| Andrew Mok CFABarclays | HoldReiterated€346.50→€359.04 | 10/29/26 | -20.71%Downside | ||
| Ben HendrixRBC Capital | BuyReiterated€444.09→€466.48 | 10/29/26 | 3.02%Upside | ||
| Matthew Gillmor CFAKeyBanc | BuyReiterated€438.72 | 10/28/26 | -3.11%Downside | ||
| Sean DodgeBMO Capital | BuyReiterated€443.20 | 10/28/26 | -2.12%Downside | ||
| Michael HaRobert W. Baird | HoldReiterated€351.87→€366.20 | 10/28/26 | -19.13%Downside | ||
| Unknown AnalystOppenheimerNot Ranked | BuyReiterated€434.24 | 10/28/26 | -4.10%Downside | ||
| Ryan LangstonTD Cowen | BuyReiterated€411.86→€435.14 | 10/28/26 | -3.90%Downside | ||
| Andrew CooperRaymond James | HoldReiterated | 09/28/26 | ― | ||
| Brian TanquilutJefferies | BuyReiterated€402.91 | 09/17/26 | -11.02%Downside | ||
| Whit MayoLeerink Partners | BuyReiterated | 09/17/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering HCA Healthcare
3 Months
Success Rate15/19 ratings generated profit
79%
Average Return
+8.16%
Copying Sarah James's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.16% per trade.
1 Year
Success Rate27/27 ratings generated profit
100%
Average Return
+22.89%
Copying Ann Hynes's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.89% per trade.
2 Years
Success Rate47/47 ratings generated profit
100%
Average Return
+54.68%
Copying Whit Mayo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +54.68% per trade.
1HCA Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 |
| Buy | 25 | 25 | 26 | 15 | 14 |
| Hold | 15 | 19 | 19 | 15 | 12 |
| Sell | 2 | 2 | 2 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 43 | 47 | 48 | 31 | 27 |
In the current month, 1HCA has received 14 Buy Ratings, 12 Hold Ratings, and 1 Sell Ratings. 1HCA average Analyst price target in the past 3 months is 416.75.
1HCA Financial Forecast
High€7.62
Consensus€7.32
Low€6.95
1HCA Earnings Forecast
Next quarter’s earnings estimate for 1HCA is EUR 7.32 with a range of EUR 6.95 to EUR 7.62. The previous quarter’s EPS was EUR 6.46. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€18.2B
Consensus€17.9B
Low€17.6B
1HCA Sales Forecast
Next quarter’s sales forecast for 1HCA is EUR 17.92B with a range of EUR 17.63B to EUR 18.16B. The previous quarter’s sales results were EUR 17.77B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
1HCA Stock Forecast FAQ
What is IT:1HCA’s average 12-month price target, according to analysts?
Based on analyst ratings, HCA Healthcare’s 12-month average price target is €416.75.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HCA Healthcare a Buy, Sell or Hold?
HCA Healthcare has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 7 hold ratings and 1 sell ratings.
What is HCA Healthcare’s share price target?
The average share price target for HCA Healthcare is €416.75. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €510.35, and the lowest forecast is €340.23. The average share price target represents a 7.96% decrease from the current price of €452.8.
What do analysts say about HCA Healthcare?
HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of HCA Healthcare?
To buy shares of IT:1HCA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
